Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2020-06-11 | 2020-06-11 |
| Drug Identification Number | 02275023 | 02275023 |
| Brand name | TEVA-VENLAFAXINE XR | TEVA-VENLAFAXINE XR |
| Common or Proper name | VENLAFAXINE XR 37.5MG CAP | VENLAFAXINE XR 37.5MG CAP |
| Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
| Ingredients | VENLAFAXINE | VENLAFAXINE |
| Strength(s) | 37.5MG | 37.5MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 100 | 100 |
| ATC code | N06AX | N06AX |
| ATC description | ANTIDEPRESSANTS | ANTIDEPRESSANTS |
| Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2020-06-08 | 2020-06-08 |
| Remaining supply date | 2020-06-08 | 2020-06-08 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Transitioned TEVA product to ACT-VENLAFAXINE. | Transitioned TEVA product to ACT-VENLAFAXINE. |
| Health Canada comments |